Disease Management Group (DMG) is the hallmark of oncology care at Medanta. DMG is an approach where for each type of cancer, a specific multidisciplinary group of specialists (including - medical oncologist, radiation oncologist, surgical oncologist) and a team of providers (physicians, nurses, pharmacists, dieticians, therapists and psychologists) collaborate and provide the best treatment modality to the patient. This DMG is supported by a Core Clinical Group (CCG) comprising of Pathologists (molecular, genetic and chemical), Nutritionists, Rehabilitation experts, Cyto-oncologists, Nuclear medicine experts, Palliative care specialists).

The DMG is a core contact point for the patient and bridges inputs across medical disciplines and between areas of research devoted to specific types of cancer. Members of DMG meet frequently to discuss all the cases and to design and prioritize clinical protocols. These meetings allow members to ensure the best multidisciplinary care for patients.

x

Advance & Specialized Technology

x

Medanta - The Medicity is the only Cancer centre in India which has all types of advance radiation technologies for treating and diagnosing different types of cancers. The Institute has the ability to detect the smallest of tumours, facilitating early treatment. The availability of Cyberknife VSI, Tomotherapy, linear accelerators with VMAT/IGRT and Integrated Brachytherapy unit ensures the complete bouquet of radiation delivery systems at Medanta-The Medicity. The treatment range from 5 mm-135 cm ensures that any tumour can be treated with complete confidence. The advance treatment technologies that Medanta Cancer Institute uses includes:

The Institute focuses not just on effects but also the side-effects of the cancer treatment with integrative and holistic treatment options. Ayurveda and other traditional systems of medicines are used to reduce the aftereffect of chemotherapy and for faster rehabilitation.

Our Specialities

At Medanta Cancer Institute, experts across specialities spanning Medical, Radiation, and Surgical oncology work together on each individual case to provide comprehensive and individualised treatment.

Medical Oncology

Medical Oncology refers to the comprehensive diagnosis and therapeutic treatment of cancerous and non-cancerous tumors through drug combinations and multi disciplinary approaches involving radiation and surgical oncologies. Types of cancer that can be treated under this branch include Breast, Lung, Brain, Thyroid and inherited cancers among the others.

The Division of Medical Oncology and Haemotology at Medanta Cancer Institute is headed by Dr. Ashok Vaid and provides the specialised and multidisciplinary approach for the treatment of aforesaid cancer types. The line of treatment and techniques that the institute uses include chemotherapy, hormone therapy, biological therapy, targeted therapy and monoclonal antibody among others. This type of treatment is often painless and since no surgical treatment is involved is incision-less also. The institute provides a one-stop-solution for cancer diagnosis and treatment including evaluation, fiducial placement, imaging, treatment planning, recovery and prevention for complete cancer removal to help patients live life normally.
Medanta Cancer Institute is dedicated to help patients provide with the best-in-class yet affordable cancer care and services. The services provided to our patients help them to lead a healthy life.

Radiation Oncology

Radiation Oncology is an advanced branch of modern cancer treatment, which is painless, incision less and preventive. The branch deals with the painless cancer treatment by using the high-dose radioactive rays, also known as X-rays. Radiation Oncology, often abbreviated as RT, RTx or XRT, involves the medical use of ionizing radiation to control or kill malignant cells without inflicting a cut in the body. Different types of cancers including Breast, Rectal, Lung and many more are treated under Radiation Oncology.

Headed by Dr. Tejinder Kataria, the Division of Radiation Oncology constitutes of the most contemporary and innovative radiosurgery techniques including CyberKnife VSI, Robotic Radiosurgery, Synergy-S, Volumetric Arc Therapy (VMAT), IGRT, SBRT/SRS, IMRT, XVI, CT Scan, PET-CT. The division has an Integrated Brachytherapy Unit for pre and post operation treatments for cancer cervix and soft tissue sarcomas along with prostate seed implants to extend ultimate conformal radiation for early tumors or as a boost along with external beam treatment.

The division provides a one-stop-solution for cancer diagnosis and treatment including evaluation, fiducial placement, imaging, treatment planning, treatment and recovery for complete cancer removal.
Medanta Cancer Institute is the pioneer of using CyberKnife VSI in India. CyberKnife VSI, introduced in 2010 by Medanta Cancer Institute, is the painless, incision less alternative to surgery for both cancerous and non cancerous tumors. Intended for Stereotactic Robotic Radiotherapies, the CyberKnife VSI is the most advanced robotic arm that offers real-time detection and tracking of cancers.

Surgical Oncology

Surgical Oncology involves the surgical treatment of benign and malignant cancerous and non cancerous tumors in the body. These may include Lung, Breast, Colon, Melanoma, Pancreatic, Prostate, Thyroid, Sarcoma, Brain, Adrenal, Liver, Head & Neck among the others.

It is used either for initial sampling of the new growth for diagnostic purposes or for definitive removal of the new growths for radical treatment. Surgical procedures may vary from small incisions to more extensive procedures needing daycare or prolonged stay.Our specialized doctors along with cutting-edge technology and Medical Intelligence enable the patients to avail personalized healthcare services.

Medanta is the only hospital that can provided integrated approach of medical and radiation oncology with surgical oncology. Our surgical experts provide following site or organ-specific treatment:

Bone & Soft Tissue - Dr. SKS Marya

Breast - Dr. Rajeev Agarwal

Central Nervous System - Dr. V P Singh

Breast Services - Dr. Kanchan Kaur

Gastrointestinal - Dr. Adarsh Choudhary

Gynaecology - Dr. Sabhyata Gupta

Head & Neck - Dr. Deepak Sarin

Urology - Dr. Rajesh Ahlawat

Liver - Dr. A. S. Soin

Urology - Dr. NP Gupta

Lung - Dr. Ali Zamar Khan

Urology - Dr. Rajiv Yadav

Advance Technologies at MCI

Medanta Cancer Institute is the only center in India, one of three in S.E Asia, one of the 14 cancer centres worldwide to offer all facilities under one roof for different cancers.

The availability of Cyberknife VSI, Tomotherapy, Linear Accelerators with VMAT/IGRT and Integrated Brachytherapy Unit ensures the complete bouquet of radiation delivery systems at Medanta -The Medicity. The treatment range from 5 mm - 135 cm ensures that any tumour can be treated with complete confidence

Robotic Radiosurgery system i.e. Magic-Knife provides a short high dose of radiation (Stereotactic Radiosurgery/Stereotactic body Radiotherapy) pointed precisely to the tumors with minimal chances of collateral damage to brain and with continuous tracking for moving organs like lungs, liver, pancreas, and prostate. The treatment is completed within 30-45 minutes/day without anesthesia and within a week. The patient can resume his/her office simultaneously with no loss of work. Commonly treated disease with Cyberknife are:

Oligometastatic disease - less than 5 in number & <5 cm in size

Brain tumours - <5 cm in size

Liver cancer

Prostate cancer

Pancreatic cancer

x

Tomotherapy H-D

x

It is the world's only integrated image-guided-intensity-modulated (IG-IMRT) delivery system. It permits helical radiation delivery that can treat tumours like medulloblastomas, acute lymphatic leukemias (Total Body Radiation) and bilateral breast cancer in a very short time. The dose to heart, lungs, and kidneys can be reduced to very low levels resulting in mitigation of acute and delayed radiation effects. Tomotherapy – is specially recommended for:

Megna-field radiotherapy in the form of total body, half body and total nodal irradiation

A cutting edge technology in brachytherapy. The tumours that have a higher control with brachytherapy are:

Cancer Cervix

Endometrial Cancer

Esophagus Cancer

Lung Cancer

Cholangiocarcinoma

The advanced dosimetry and standardized processes at Medanta Cancer Institute ensures that patients do not miss their treatment if one of the machines is under maintenance or repair. In case you have a breakdown or delay on your treatment units, we shall be ready to provide treatment to you patients to maintain continuity of care.

Patient Testimonials

Learn About Cancer

Brain - Benign

Benign Brain Lesions are small space occupying areas in the Brain that are slow growing and do not carry risk of aggressive growth locally or systemically. Still because of mass effect they may cause symptoms of headache/vomiting seizures or related to the specific area of the Brain where they are located. Benign Brain Lesions usually can be kept under close observation till the time they get symptomatic.

Brain - Malignant

A benign or malignant growth in the Brain. Primary Brain tumours initially form in Brain tissue. Secondary Brain tumours are cancers that have spread (metastasized) to the Brain tissue from tissue elsewhere in the body. Brain tumours can occur in people of any age.

Brain and Spinal Cord Tumours

Spinal Cord Tumours can be either Benign, Malignant primary that is primarily arising from the spine or has come from some other primary site and tumour cells get deposited and start growing in spinal area. A spinal tumour or a growth of any kind can affect nerves in the area of the tumour, leading to pain, neurological problems and sometimes paralysis. Whether cancerous or not, a spinal tumour can threaten life and cause permanent disability.

Nasopharyngeal Cancer

Nasopharynx is a very small area of the Head & Neck area in between our eyes and above the nasal cavity. Due to its proximity to vital nerves and subsites like eyes, visual pathway nerves,. Nasopharyngeal Cancer is a cancer that starts in the nasopharynx, the upper part of the throat behind the nose and near the base of skull.

Paranasal Sinus and Nasal Cavity Cancer

'Paranasal' means near the nose. The paranasal sinuses are hollow, air-filled spaces in the bones around the nose. Paranasal Sinus and Nasal Cavity Cancer is a disease in which malignant cells form in the tissues of the paranasal sinuses and nasal cavity.

Lip and Oral Cavity Cancer

Lip and Oral Cavity (Tongue/Floor of mouth/Palate/ Gums/Cheek/Teeth) is one of the important sub site of Head & Neck and is of vital importance as it forms the inlet for our body and responsible for all our nutrition/ taste/ phonation, etc. Lip and Oral Cavity Cancer is a disease in which cancer (malignant) cells are found in the tissues of the lip or mouth. The oral cavity includes the front two thirds of the tongue, the upper and lower gums (the gingiva), the lining of the inside of the cheeks and lips (the buccal mucosa), the bottom (floor) of the mouth under the tongue, the bony top of the mouth (the hard palate) and the small area behind the wisdom teeth (the retromolar trigone).

Oropharyngeal Cancer

Oropharynx is an area that connects Oral Cavity to the upper part of the Neck and forms a small pouch carrying important subsites of Head & Neck. Oropharyngeal Cancer is a disease in which malignant cells form in the tissue of oropharynx.

Laryngeal Cancer

Larynx or the Voice Box is one of the most important site of Head & Neck area and helps in phonation. These cancers generally present early due to early change in voice, apart from other common generalised cancer symptoms. Cancer that forms in tissues of the larynx (area of the throat that contains the vocal cords and is used for breathing, swallowing and talking). Most Laryngeal Cancers are Squamous Cell carcinomas (cancer that begins in flat cells lining the Larynx).

Hypopharyngeal Cancer

Hypopharyngeal area of Head & Neck is a small area which forms a common junction of the food pipe and wind pipe in the body. Smoking, like Lung Cancer, can cause Hypopharyngeal Cancer because it contains carcinogens that alter the DNA or RNA in a dividing cell. Chewing tobacco can have the same effects as smoking and is also linked to Hypopharyngeal Cancer. Heavy alcohol use is linked to Hypopharyngeal Cancer as well.

Metastatic Squamous Neck Cancer with Occult Primary

There can be situations where patient present with Neck Nodes, but no primary focus of the disease in Head & Neck region even after through investigations from all possible modalities. Metastatic Squamous cells are thin, flat cells found in tissues that form the surface of the skin and the lining of body cavities such as the mouth, hollow organs such as the uterus and blood vessels and the lining of the respiratory (breathing) and digestive tracts. Some organs with squamous cells are the esophagus, lungs, kidneys and uterus. Cancer can begin in squamous cells anywhere in the body and metastasize (spread) through the blood or lymph system to other parts of the body.

Parathyroid Cancer

Parathyroid Cancer is a malignant (cancerous) growth in a parathyroid gland. This type of cancer is primarily caused by Hypercalcemia (high levels of calcium in the blood) and may affect various parts of the body. People who had head or neck radiation may also be at increased risk. Such radiation exposure, however, is more often connected with Thyroid Cancer.

Lung Cancer

Lung malignancies are common due to prevalence of smoking and other risk factors. Malignancies of Lung are either primarily arising from the lung or appear in lung after being disseminated through blood from other pre-existing cancerous area of the body. The most common cause is long-term exposure to tobacco smoke, which causes 80-90% of lung cancers. Non-smokers account for 10-15% of lung cancer cases and these cases are often attributed to a combination of genetic factors and exposure to; radon gas, asbestos and air pollution including second-hand smoke.

Oesophagus Cancer

Oesophagus cancer is also known as Esophageal Cancer, which is a type of cancer found in Esophagus, the food pipe running between the throat and the stomach. Trouble in swallowing, weight loss, hoarse voice and dry cough may indicate the presence of an esophageal tumor. The intake of alcohol, smoking and excessive hot drinks may lead to the formation of Esophageal Cancer in this organ.

Breast Cancer

Breast Cancers are Malignant Tumors that develop in Breast tissues and can happen in both males and females. Most commonly seen in females as compared with males, the cancer of breast can either develop the surrounding tissues or metastasize (spread) into the other parts of the body like Bone, Brain, Liver or Lungs. Some of the common causes of Breast Cancer include pre-existing condition like cyst or fibrosis, smoking, alcohol consumption or hormonal changes in the body. This type of cancer is dangerous as it is one of the leading causes of death in females and males also.

Breast Cancer

Breast Cancers are Malignant tumours of the Breast tissue and can happen in both males and females. Most commonly seen in females and has high risks of spreading to other parts of the body like Bone, Brain, Liver or Lungs.

Pancreas Cancer

Pancreatic Cancer develops in the Pancreas, which is a glandular organ placed behind the stomach, but ahead of the Spine. Responsible for maintaining the blood sugar level in the body by discharging hormones (glycogen and insulin) and digestive juices, the pancreas involves endocrine and exocrine cells. The majority of abnormalities usually occur in exocrine cells, leading to stomach ache or backache, sudden weight loss, jaundice and more. The cancer is mainly caused by smoking, diabetes, genetic conditions and obesity among the leading causes. The Pancreatic Cancer is usually difficult to treat as it reaches the advanced stage way before it is diagnosed.

Liver Cancer

Liver Cancer, also called Hepatic cancer, is a type of cancer occurring in Liver, which is the largest internal organ as well as the largest gland in the body of a human being. Lying in the right upper quadrant of Abdomen and below the diaphragm, its position and movement with respiration makes it unique and complex while planning procedures. A viral infection with hepatitis B or hepatitis C virus may cause Liver Cancer.

Gall Bladder Cancer

Despite being a rare disease, the incidents of Gall Bladder Cancer are rising in India and other parts of the world, including China, America and some areas of the Eastern Europe. The cancer develops in Gall Bladder, which is small (pear-shaped) organ laying right under the liver in the Abdomen. Jaundice, abdominal pain, vomiting, fever, lumps, bloating and nausea are among several symptoms that may occur in the person suffering from Gall Bladder Cancer. The presence of this cancer is more common in women in their 70s or 80s than men. Some of the causes leading to the formation of the cancer include gall stones, inflammation, congenital abnormal bile ducts, smoking, obesity and hereditary problem among others.

Kidney (Renal Cell) Cancer

Renal cell carcinoma is a Kidney Cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport waste molecules from the blood to the urine. Renal cell carcinoma is the most common type of Kidney Cancer in adults, responsible for approximately 90-95% of cases. It has been described as one of the deadliest of cancers affecting the genitourinary tract. It is the seventh most common cancer in men and the ninth most common in women. Inhaled tobacco smoke is clearly implicated in the etiology of Renal cell carcinoma, with a strong dose-dependent increase in risk associated with numbers of cigarettes smoked per day and a substantial reduction in risk for long-term former smokers.

Renal Pelvis and Ureter Cancer, Transitional Cell

Cancer of the renal pelvis or ureter is cancer that forms in the Kidney's Pelvis or the tube that carries urine from the Kidney to the Bladder. Cancer can grow in the urine collection system, but is uncommon. As a group, renal pelvis and ureter cancers account for about 5% of all cancers of the Kidney and upper urinary tract. They affect men more often than women and are more common in people older than 65. The causes of this cancer are not completely known. Long-term (chronic) irritation of the kidney from harmful substances removed in the urine may be a factor.

Bladder Cancer

Bladder Cancer affects the urinary bladder and is usually detected on evaluation for urinary complaints or blood in urine. Tobacco smoking is the main known contributor to urinary bladder cancer; in most populations, smoking is associated with over half of bladder cancer cases in men and one-third of cases among women.

Prostate Cancer

Prostate Cancer is one of the most commonly detected cancers in male. Prostate Cancer is cancer that occurs in a man's prostate - a small walnut-shaped gland that produces the seminal fluid that nourishes and transports sperm. Prostate Cancer usually grows slowly and initially remains confined to the prostate gland, where it may not cause serious harm. While some types of prostate cancer grow slowly and may need. Minimal or no treatment, other types are aggressive and can spread quickly. With increasing awareness and screening modality by serum PSA, more and earlier stage cancer Prostates are reporting to clinic.

Liver Cancer

Liver cancer normally occurs in 95% of the cases in people who already have liver disease due to hepatitis B, hepatitis C, Alcoholic Liver Disease or Fatty Liver Disease or one of the rarer causes of liver disease. Only rarely does cancer in the liver arise in an absolutely healthy liver.

To diagnose liver cancer, one should have screening if one falls in a high risk group. If anyone of them suffers any of these diseases, they should have blood test call Alpha Fetoprotein, an ultrasound of liver in every three months and a CT scan of liver in every 6-12 months. If someone has found a lump in the liver in any of these test then further tests are needed to find out.

To know the extent of liver cancer, to know if it has gone beyond the liver and if it has entered the blood vessel of the liver a PET Triphasic CT Scan of the abdomen and the liver is done. This basically tells where the cancer in liver is, whether it’s revolving the important structures within or outside the liver and if it’s spread outside the liver, where all it is. Once liver cancer is diagnosed comes the treatment. The best treatment for liver cancer can be done in a specialized institute, the kind of institute Medanta Institute of Liver Transplant and Regenerative Medicine is. We have all kinds of treatment available for liver cancer, starting with the burning treatment which is called the Radio Frequency Ablation (RFA) that’s meant for very small tumors up to 2 cm. If the tumor is bigger or multiple the idle treatment is to remove those tumors. If those tumors are on one side of the liver and the rest of the liver is fairly well functioning then something called Liver Resection, which is a removal of the part of the liver that bears the tumor, can be done. However if the cancer is spread throughout the liver or if it’s beyond the certain size, that is beyond 3 or 3.5 cm then a liver transplant is the ideal treatment.

The reason why liver transplant is an ideal treatment for liver cancer that has not spread outside the liver is because there is a 90% chance that liver cancer will return to the same liver with alternate treatment like removing or burning the cancer. That’s why liver transplant is the final cure for stage 1 and stage 2 liver cancer. If the liver cancer has spread into the blood vessels or outside the liver, then curative liver transplant is not possible but some other treatment options like Transarterial Radioembolisation (TARE), Stereotactic Body Radiation Therapy or Palliative Transarterial Chemoembolisation (TACE) are possible. If the cancer is very advanced then some medical treatment is also available.

Book an Appointment

Contact

PRIVACY POLICY

Medanta - The Medicity ("Medanta") is committed to the protection of the information that you may provide to us ("Confidential Information"). We at Medanta take appropriate security measures to protect such Information against unauthorized access or disclosure.
We restrict access to your Information only to such persons who need to know that information in order to provide services to you.

Type of Information and source of collection

We collect information about you when you visit our Website and/ or through your physical interaction with our staff.The type of information which we generally collect is your name, address, age, sex or medical report(s)/ history, physical, physiological and mental health condition or any other information as required to provide you desired services.
We will not disclose above information to any other person unless required for providing you the desired services or required under the Law or if the information is already in public domain. You may choose to not provide any sensitive information to us, if you feel and find it to be confidential / sensitive.
We never collect bank/credit card information of the Information Provider.
You are deemed to have provided your consent to share the information with concerned persons while providing you the desired services as above. You may withdraw your consent in writing at any time and we shall have the option not to provide the services for which information was provided.

Data security & electronic data encryption

The information collected from you by us is secured and can be accessed by the authorised persons only.
We have implemented adequate security practices and standards with necessary controls commensurate with the information being provided.

Purpose and use of information

We may use the information shared by you for the purpose of providing various services offered by the Hospital.

Disclosure/sharing of information

We may share your information:

With concerned persons who need to use the same for authorised purpose/ providing desired services.

To protect and defend the right and property of Hospital.

Wherever required by law / Govt. Agencies.

With you if you may desire so subsequently

The information shared by you shall not be displayed by us for any promotional activity
We shall address any discrepancies and grievances of provider of the information with respect to processing of information in a time bound manner. For this purpose, we have designated Medical Superintendent as Grievance Officer of the Company. He can be reached as per following details:

Medanta reserves the right to update, change or modify this Policy at any time. Please read the Policy periodically especially before you provide any Confidential Information. We welcome your feedback, queries and suggestions please contact us by emailing us at feedback@medanta.org.

Form Error

OOPS!!! There seems to be some problem while submitting the form. Please try again.